These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24402013)

  • 21. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.
    Boelaert K; Horacek J; Holder RL; Watkinson JC; Sheppard MC; Franklyn JA
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4295-301. PubMed ID: 16868053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased incidence of euthyroid and hyperthyroid goiters independently of thyrotropin in patients with acromegaly.
    Wüster C; Steger G; Schmelzle A; Gottswinter J; Minne HW; Ziegler R
    Horm Metab Res; 1991 Mar; 23(3):131-4. PubMed ID: 1907592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An association between acromegaly and thyroid carcinoma.
    Balkany C; Cushing GW
    Thyroid; 1995 Feb; 5(1):47-50. PubMed ID: 7787433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiated thyroid carcinoma in sporadic and familial presentations of acromegaly: A case series.
    Rogozinski A; Daly AF; Reyes A; Furioso A; Beckers A; Lowenstein A
    Ann Endocrinol (Paris); 2020 Oct; 81(5):482-486. PubMed ID: 32822652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid gland changes in patients with acromegaly.
    Natchev E; Vandeva S; Kovatcheva R; Kirilov G; Kalinov K; Zacharieva S
    Arch Endocrinol Metab; 2020; 64(3):269-275. PubMed ID: 32555993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of thyroid cancer in patients with acromegaly and non-growth hormone secreting pituitary adenomas: A prospective cross-sectional study.
    Spricido IY; Feckinghaus CM; Silva RHM; Mesa Junior CO; Boguszewski CL
    Growth Horm IGF Res; 2021 Feb; 56():101378. PubMed ID: 33486451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin-like growth factor I levels.
    Miyakawa M; Saji M; Tsushima T; Wakai K; Shizume K
    J Clin Endocrinol Metab; 1988 Nov; 67(5):973-8. PubMed ID: 3053751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid cancer is the most common cancer associated with acromegaly.
    Gullu BE; Celik O; Gazioglu N; Kadioglu P
    Pituitary; 2010 Sep; 13(3):242-8. PubMed ID: 20217483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The thyroid gland in acromegaly: an ultrasonographic study.
    Cheung NW; Boyages SC
    Clin Endocrinol (Oxf); 1997 May; 46(5):545-9. PubMed ID: 9231049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid Disorders in Saudi Patients With Acromegaly: A Tertiary Care Center Experience.
    Alsuraikh MA; Almalki E; Bazuhair T; Almalki M
    Cureus; 2024 Feb; 16(2):e53663. PubMed ID: 38455769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence of benign and malignant tumors in patients with acromegaly at a single institute.
    Kurimoto M; Fukuda I; Hizuka N; Takano K
    Endocr J; 2008 Mar; 55(1):67-71. PubMed ID: 18202526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal Lymphocytic Thyroiditis Nodules Share the Features of Papillary Thyroid Cancer on Ultrasound.
    Hwang S; Shin DY; Kim EK; Yang WI; Byun JW; Lee SJ; Kim G; Im SJ; Lee EJ
    Yonsei Med J; 2015 Sep; 56(5):1338-44. PubMed ID: 26256977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Experience of a Single Tertiary Center Regarding Benign and Malignant Tumors in Acromegalic Patients.
    Plotuna IS; Balas M; Golu I; Amzar D; Vlad A; Moleriu LC; Vlad M
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374352
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis.
    Antonelli A; Ferri C; Fallahi P; Cazzato M; Ferrari SM; Sebastiani M; Ferrannini E
    Eur J Endocrinol; 2007 Apr; 156(4):431-7. PubMed ID: 17389457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid lesions in patients with acromegaly - case-control study and update to the meta-analysis.
    Woliński K; Stangierski A; Gurgul E; Bromińska B; Czarnywojtek A; Lodyga M; Ruchała M
    Endokrynol Pol; 2017; 68(1):2-6. PubMed ID: 28255974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased thyroid cancer risk in acromegaly.
    Dagdelen S; Cinar N; Erbas T
    Pituitary; 2014 Aug; 17(4):299-306. PubMed ID: 23836362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of ultrasonography in predicting autoimmune thyroid disease.
    Pedersen OM; Aardal NP; Larssen TB; Varhaug JE; Myking O; Vik-Mo H
    Thyroid; 2000 Mar; 10(3):251-9. PubMed ID: 10779140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of serum IGF-I and IGFBP-3 in growth hormone disorders in adults.
    Kim HJ; Kwon SH; Kim SW; Park DJ; Shin CS; Park KS; Kim SY; Cho BY; Lee HK
    Horm Res; 2001; 56(3-4):117-23. PubMed ID: 11847474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects.
    Colao A; Marzullo P; Spiezia S; Ferone D; Giaccio A; Cerbone G; Pivonello R; Di Somma C; Lombardi G
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1986-91. PubMed ID: 10372698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A retrospective analysis of thyroid cancer.
    Ertürk E; Tuncel E; Yerci O; Gürsoy N; Imamoğlu S; Koran N; Arinik A
    J Environ Pathol Toxicol Oncol; 1996; 15(2-4):245-9. PubMed ID: 9216815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.